![NEIL Bajpayee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of NEIL Bajpayee
Former positions of NEIL Bajpayee
Companies | Position | Start | End |
---|---|---|---|
Kairos Venture Investments LLC
![]() Kairos Venture Investments LLC Investment ManagersFinance Kairos Venture Investments LLC (Kairos Venture) is a venture capital firm founded in 2015 by Jim Demetriades. The firm is headquartered in Beverly Hills, California. | Private Equity Investor | 2018-03-31 | 2020-10-29 |
Actuate Therapeutics, Inc.
![]() Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Director/Board Member | 2019-04-30 | 2020-10-29 |
Training of NEIL Bajpayee
The Pennsylvania State University | Undergraduate Degree |
University of California | Doctorate Degree |
Statistics
International
United States | 5 |
Operational
Undergraduate Degree | 1 |
Private Equity Investor | 1 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 3 |
Finance | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Kairos Venture Investments LLC
![]() Kairos Venture Investments LLC Investment ManagersFinance Kairos Venture Investments LLC (Kairos Venture) is a venture capital firm founded in 2015 by Jim Demetriades. The firm is headquartered in Beverly Hills, California. | Finance |
Actuate Therapeutics, Inc.
![]() Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Health Technology |
- Stock Market
- Insiders
- NEIL Bajpayee
- Experience